ストックスクリーナーアプリを入手
1.67
3.09%
0.05
アフターアワーズ：
1.64
-0.03
-1.80%
前日終値:
$1.62
開ける：
$1.65
24時間の取引高:
3.24M
Relative Volume:
0.59
時価総額：
$265.25M
収益：
-
当期純損益:
$-110.78M
株価収益率:
-1.5607
EPS:
-1.07
ネットキャッシュフロー:
$-75.59M
1週間 パフォーマンス:
-2.34%
1か月 パフォーマンス:
-4.02%
6か月 パフォーマンス:
+15.17%
1年 パフォーマンス:
-66.93%
1日の値動き範囲:
$1.60
$1.67
1週間の範囲:
$1.60
$1.78
52週間の値動き範囲:
$1.15
$6.77
Humacyte Inc Stock (HUMA) Company Profile
名前
Humacyte Inc
セクター
電話
919-313-9633
住所
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
HUMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.67 | 303.38M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-27 | 開始されました | Barclays | Overweight |
| 2025-05-14 | 再開されました | H.C. Wainwright | Buy |
| 2024-12-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-12-11 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-14 | アップグレード | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-05-16 | ダウングレード | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 開始されました | Cowen | Outperform |
| 2021-09-24 | 開始されました | Oppenheimer | Outperform |
| 2021-09-22 | 開始されました | BTIG Research | Buy |
| 2021-09-16 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Humacyte Inc (HUMA) 最新ニュース
Using data models to predict Humacyte Inc. Equity Warrant stock movementWeekly Risk Report & Consistent Profit Alerts - newser.com
Humacyte rises on Symvess sale to military treatment facility - MSN
Multi asset correlation models including Humacyte Inc. Equity WarrantRate Cut & Verified Momentum Watchlists - newser.com
Technical analysis overview for Humacyte Inc. Equity Warrant stockMarket Risk Analysis & Weekly High Return Opportunities - newser.com
Why Humacyte Inc. Equity Warrant stock could outperform in 2025July 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
Tick level data insight on Humacyte Inc. volatilityWeekly Stock Recap & Growth Focused Entry Point Reports - newser.com
Will Humacyte Inc. Equity Warrant stock see insider buying2025 Earnings Impact & Fast Moving Trade Plans - newser.com
Key metrics from Humacyte Inc.’s quarterly dataMarket Weekly Review & Community Supported Trade Ideas - newser.com
Is Humacyte Inc. stock trading near support levelsGap Up & Weekly Chart Analysis and Trade Guides - newser.com
Is Humacyte Inc. Equity Warrant stock vulnerable to regulatory risksJuly 2025 Final Week & Real-Time Stock Price Movement Reports - newser.com
Earnings visualization tools for Humacyte Inc.Profit Target & Consistent Profit Alerts - newser.com
Will Humacyte Inc. stock benefit from infrastructure spending2025 Key Highlights & High Return Stock Watch Alerts - newser.com
Why Humacyte Inc. stock remains on buy listsCPI Data & High Return Stock Watch Alerts - newser.com
Is Humacyte Inc. Equity Warrant stock ready for a breakout2025 Biggest Moves & Real-Time Sentiment Analysis - newser.com
What recovery options are there for Humacyte Inc. Equity Warrant2025 Technical Overview & Daily Stock Trend Watchlist - newser.com
Predicting Humacyte Inc. trend using moving averages2025 Performance Recap & Entry Point Strategy Guides - newser.com
Historical volatility pattern of Humacyte Inc. Equity Warrant visualized2025 Buyback Activity & Target Return Focused Picks - newser.com
Tick level data insight on Humacyte Inc. Equity Warrant volatilityWatch List & Momentum Based Trading Ideas - newser.com
Using RSI to spot recovery in Humacyte Inc. Equity WarrantWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
Can Humacyte Inc. stock reach $100 price target2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
Is Humacyte Inc. Equity Warrant stock a dividend growth opportunityTreasury Yields & Real-Time Chart Pattern Alerts - newser.com
Humacyte, Inc. (HUMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Chart overlay techniques for tracking Humacyte Inc.Weekly Volume Report & Entry Point Confirmation Signals - newser.com
Humacyte Announces Publication of New Data Comparing Symvess™ to Autologous Vein in Extremity Arterial Trauma - The Manila Times
Humacyte (NASDAQ: HUMA) says Symvess matches vein in limb trauma; 86.6% patency - Stock Titan
Should I hold or sell Humacyte Inc. Equity Warrant stock in 2025Trade Exit Report & Advanced Swing Trade Entry Plans - newser.com
Market reaction to Humacyte Inc.’s recent newsWeekly Trade Review & Reliable Trade Execution Plans - newser.com
Will Humacyte Inc. stock deliver shareholder value2025 Sector Review & Safe Capital Preservation Plans - newser.com
Published on: 2025-10-29 21:20:23 - newser.com
How Humacyte Inc. Equity Warrant stock benefits from strong dollarGap Up & High Accuracy Trade Alerts - Fundação Cultural do Pará
Humacyte Inc (HUMA) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):